Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 22, Number 1—January 2016

Dispatch

Factors Related to Fetal Death in Pregnant Women with Cholera, Haiti, 2011–2014

Tables

Altmetric

Metric Details
1
citations of this article
EID Journal Metrics on Scopus
Erin Schillberg, Cono Ariti, Lindsay Bryson, Rodnie Delva-Senat, Debbie Price, Reynold GrandPierre, and Annick LengletComments to Author 
Author affiliations: Médecins Sans Frontières, Port-au-Prince, Haiti (E. Schillberg, L. Bryson, R. Delva-Senat); London School of Hygiene and Tropical Medicine, London, UK (C. Ariti); Médecins Sans Frontières, Amsterdam, the Netherlands (D. Price, A. Lenglet); Ministère de la Santé Publique et de la Population, Port-au-Prince (R. GrandPierre)

Cite This Article

Close

Highlight and copy the desired format.

EID Schillberg E, Ariti C, Bryson L, Delva-Senat R, Price D, GrandPierre R, et al. Factors Related to Fetal Death in Pregnant Women with Cholera, Haiti, 2011–2014. Emerg Infect Dis. 2016;22(1):124-127. https://dx.doi.org/10.3201/eid2201.151078
AMA Schillberg E, Ariti C, Bryson L, et al. Factors Related to Fetal Death in Pregnant Women with Cholera, Haiti, 2011–2014. Emerging Infectious Diseases. 2016;22(1):124-127. doi:10.3201/eid2201.151078.
APA Schillberg, E., Ariti, C., Bryson, L., Delva-Senat, R., Price, D., GrandPierre, R....Lenglet, A. (2016). Factors Related to Fetal Death in Pregnant Women with Cholera, Haiti, 2011–2014. Emerging Infectious Diseases, 22(1), 124-127. https://dx.doi.org/10.3201/eid2201.151078.

Abstract

We assessed risk factors for fetal death during cholera infection and effect of treatment changes on these deaths. Third trimester gestation, younger maternal age, severe dehydration, and vomiting were risk factors. Changes in treatment had limited effects on fetal death, highlighting the need for prevention and evidence-based treatment.

Cholera infections during pregnancy are associated with high rates of fetal death, especially when women are severely dehydrated (17). In Haiti in 2011, pregnant women with clinical signs of cholera who sought treatment from Médecins Sans Frontières (MSF) in Port-au-Prince were sent to a general cholera treatment center (CTC). In April 2012, MSF established a CTC to improve fetal outcomes in pregnant women by facilitating intensive follow-up for dehydration and rapid access to obstetric and neonatal services. In June 2013, a more aggressive rehydration protocol was implemented (Technical Appendix Table 1). To assess the effects of cholera infection, establishment of a specialized CTC, and the new rehydration protocol, we conducted a retrospective cohort analysis of pregnant women with suspected cholera admitted to MSF’s CTCs during September 1, 2011−December 31, 2014.

The Study

This study was approved by the National Bioethical Committee of the Ministry of Public Health and Population of Haiti. A cholera case-patient was defined as someone who passed >3 liquid stools with or without vomiting or dehydration in the previous 24 hours or within 6 hours of seeking treatment. Women of childbearing age were asked whether they were pregnant. Urine dipstick tests were conducted in cases of uncertainty or early stages of pregnancy. Gestational age was determined by date of the woman’s last menstruation, uterine height, or ultrasound. Fetal status was assessed at admission and hourly by using fetal stethoscope or ultrasonic fetal Doppler. Women who had a miscarriage at home and were not bleeding at admission were not classified as pregnant. Dehydration status was determined according to World Health Organization categories (Technical Appendix Table 1) (8). We assigned women into 3 treatment groups (TGs) according to whether they were treated in the general or specialized CTC and whether they were given the original or new protocol (Technical Appendix Table 1).

We analyzed fetal outcome for all pregnant women by initial signs and symptoms, TG, and clinical evolution. Multiple logistic regression modeling was used for adjusted analyses. All analyses used Stata software version 12.0 (StataCorp LP, College Station, TX, USA).

During September 1, 2011−December 31, 2014, a total of 936 pregnant women were admitted. Thirty-six were excluded from analysis: 33 (0.35%) lacked fetal outcome data, and 3 (0.03%) died (1 each during second and third trimester; for 1, trimester was unknown). Of the remaining 900, mean age was 26.7 years (range 15–48, median 26 years); 168 (18.9%) were in their first trimester, 303 (34.2%) second trimester, and 416 (46.9%) third trimester. Trimester was unknown for 13. A total of 444 (49.3%) sought treatment within 24 hours of symptom development.

Fetal death occurred in 141 (15.7%) of the 900 analyzed pregnancies, more often in women <20 years of age (odds ratio [OR] 2.0, 95% CI 1.2–3.2), in their third trimester (OR 2.4, 95% CI 1.4–4.3), seeking treatment >24 hours after symptom onset (OR 1.5, 95% CI 1.0–2.2), with severe dehydration (OR 2.2, 95% CI 1.2–3.8), or who vomited (OR 2.1, 95% CI 1.3–3.5) (Table 1). A total of 64 (45.4%) fetal deaths occurred before admission.

Women who experienced preadmission or postadmission fetal death did not differ by age or clinical presentation (Technical Appendix Table 2). However, preadmission fetal death was more likely in women who arrived >24 hours after symptom onset (OR 1.9, 95% CI 0.9–4.1) or were severely dehydrated (OR 2.0, 95% CI 0.7–5.7). In unadjusted analysis, postadmission fetal death was associated with moderate dehydration (OR 2.1, 95% CI 1.2–3.6) and vomiting (OR 2.1, 95% CI 1.2–3.8; Table 2). Of 836 women with a viable fetus at admission, 120 were in TG1, 399 in TG2, and 317 in TG3.

There was no modification effect of TG on postadmission fetal death. Weak evidence of a difference in effect of severe dehydration on postadmission fetal death between TGs (p = 0.09) (Table 2) was potentially due to a lower rate among severely dehydrated women in TG2 (OR 0.4. 95% CI 0.1–1.7; data not shown). However, there was insufficient power to detect these differences, and the final model did not require adjustment. Although the proportion of postadmission fetal deaths within a TG decreased with each protocol change, the proportion in TG3 (8.5%, 27/317) was not different from TG1 (10.0%, 12/120) or TG2 (9.5%; 38/399).

Conclusions

Fetal death occurred in 141 (16%) of 900 pregnancies. Risk factors were third trimester, younger maternal age, severe dehydration, and vomiting. Treatment in a specialized CTC and aggressive rehydration did not prevent fetal death though the trend was toward improved outcomes.

Severe dehydration at admission increased risk for fetal death (2,57). Fetal death may occur due to fetal hypoxia and acidosis resulting from excessive maternal dehydration (2,4,9). The proportion of fetal deaths we found was higher than that previously recorded in Haiti (8%, 21/263) (2) but close to that of the 2006 Senegal cholera outbreak (12%, 6/52) (3). Earlier studies in India (4), Nigeria (1,7), and Pakistan (6) found higher proportions.

Women <20 years of age were twice as likely as older women to experience fetal death. Although the relationship between fetal death and maternal age during cholera has not been documented, younger age is associated with increased risk for other adverse pregnancy outcomes (10). The risk for fetal death was highest in the third trimester, even after controlling for maternal age, dehydration level, and vomiting. The relationship between fetal death and trimester of pregnancy is unclear (1,3,6).

Determination of dehydration status of pregnant women is difficult in later stages of pregnancy (2,11). Misclassification of dehydration status could affect fetal outcome due to placement of patients under the wrong treatment protocol. In addition, increased placental blood flow with gestational age may increase the effect of dehydration (12). Even after we controlled for dehydration level, we determined that fetal death was twice as likely in women experiencing vomiting, potentially due to electrolyte changes in amniotic fluid (2,7,1315).

Lack of effect of a specialized CTC on fetal death could result from a detection bias in that establishment of the specialized CTC led to an increased likelihood of detection of fetal deaths. In addition, 45% of fetal deaths occurred before women sought treatment. Fetal death may occur early in a pregnant woman’s illness with cholera (6), and more than half the women sought treatment >24 hours after symptom onset, likely contributing to poor fetal outcomes. Likewise, the effect of the new treatment protocol may have been limited by fetal death occurring before the women sought treatment or by women being assigned the incorrect protocol due to difficulty in determining dehydration status.

Limitations include lack of laboratory-confirmed diagnoses. Data were collected for programmatic rather than research purposes and lack electrolyte levels, amniotic fluid composition, maternal blood group, and fetal cause of death. Some first-trimester pregnancies may have been missed. Pregnancies in women who completed miscarriage at home were not counted, potentially underestimating overall risk for fetal death. Because there was no follow-up of women after discharge, some early-term fetal deaths might have been missed. In addition, the long-term effect of treatment on fetal well-being could not be determined. TG outcomes also may have been affected by differences in factors such as women’s access to health services over time.

Although the implementation of a specialized CTC did not decrease fetal deaths, specialized CTCs play a vital role in preserving patients’ dignity and providing patient-centered care. Determining the mechanism of fetal death in cholera infection would enable development of evidence-based treatment protocols. Because many fetal deaths occurred before women sought treatment, the importance of cholera prevention and the risk for poor fetal outcomes should be emphasized.

Mrs. Schillberg is an epidemiologist with Médecins Sans Frontières. Her research interests include emerging and reemerging infectious diseases among vulnerable populations.

Top

Acknowledgments

We thank all staff working on cholera in Port-au-Prince, especially the midwives, nurses, and obstetricians who provided quality patient-centered care for pregnant women with cholera. We thank Sarah Venis for editing assistance.

E.S. had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. E.S. and C.A. analyzed the data, and E.S. drafted the manuscript. A.L. supervised the epidemiologic analysis, and L.B. and R.S.D. coordinated the data collection. All authors contributed to the conception and design of the study and to the interpretation of the data. All authors critically revised the manuscript for intellectual content and approved the final draft for submission. The study design, data collection, analysis, decision to publish, and preparation of the manuscript was approved by Médecins Sans Frontières and the Haitian Ministry of Health.

Top

References

  1. Ayangade  O. The significance of cholera outbreak in the prognosis of pregnancy. Int J Gynaecol Obstet. 1981;19:4037. DOIPubMed
  2. Ciglenecki  I, Bichet  M, Tena  J, Mondesir  E, Bastard  M, Tran  NT, Cholera in pregnancy: outcomes from a specialized cholera treatment unit for pregnant women in Léogâne, Haiti. PLoS Negl Trop Dis. 2013;7:e2368. DOIPubMed
  3. Diop SA, Manga NM, Dia NM, Gaye S, Ndour CT, Seydi M, et al. Cholera and pregnancy: epidemiological, clinical, and evolutionary aspects [in French]. Med Mal Infect. 2007;37:81620. DOIPubMed
  4. Khan  PK. Asiatic cholera in pregnancy. Int Surg. 1969;51:13841.PubMed
  5. Grados  P, Battilana  CA. Treatment of choleriform diarrhea during pregnancy [in Spanish]. Bol Oficina Sanit Panam. 1994;116:198203.PubMed
  6. Hirschhorn  N, Chowdhury  AK, Lindenbaum  J. Cholera in pregnant women. Lancet. 1969;1:12302. DOIPubMed
  7. Ogunbode  O, Onifade  A. Amniotic fluid electrolytes, urea and creatinine in normal pregnancy and cholera during pregnancy. Obstet Gynecol. 1972;39:4415.PubMed
  8. Brookes  CM. Fetal heart rate monitoring casebook. Fetal heart block in presence of maternal hypokalemia. J Perinatol. 1988;8:1713.PubMed
  9. World Health Organization Global Task Force on Cholera Control. Case management: treatment. In: Cholera outbreak: assessing the outbreak response and improving preparedness. Geneva: The Organization; 2010. p. 26–30.
  10. Balayla  J, Azoulay  L, Assayag  J, Benjamin  A. Abenhaim HA. Effect of maternal age on the risk of stillbirth: a population-based cohort study on 37 million births in the United States. Am J Perinatol. 2011;28:64350. DOIPubMed
  11. Harris  JB, LaRocque  RC, Qadri  F, Ryan  ET, Calderwood  SB. Cholera. Lancet. 2012;379:246676. DOIPubMed
  12. Kerr  MG. Cardiovascular dynamics in pregnancy and labour. Br Med Bull. 1968;24:1924.
  13. Rozenberg  A, Leonetti  P. Traumatismes de la femme enceinte. Société Française de Médicine d’Urgence: 51e Congrès national d’anaesthésie et de réanimation [cited 2015 Nov 17]. http://sofia.medicalistes.org/spip/IMG/pdf/Traumatisme_de_la_femme_enceinte.pdf
  14. Sutton  MS, Theard  MA, Bhatia  SJ, Plappert  T, Saltzman  DH, Doubilet  P. Changes in placental blood flow in the normal human fetus with gestational age. Pediatr Res. 1990;28:3837. DOIPubMed
  15. Montoro  MN, Myers  VP, Mestman  JH, Xu  Y, Anderson  BG, Golde  SH. Outcome of pregnancy in diabetic ketoacidosis. Am J Perinatol. 1993;10:1720. DOIPubMed

Top

Tables

Top

Cite This Article

DOI: 10.3201/eid2201.151078

CrossRef reports the volume should be "293" not "1" in reference 6 "Hirschhorn, Chowdhury, Lindenbaum, 1969".

Medline indexes "Br Med Bull" but cannot find a listing for reference 12 "Kerr, 1968". Please check the reference for accuracy.

CrossRef reports the first page should be "17" not "7" in reference 15 "Montoro, Myers, Mestman, Xu, Anderson, Golde, 1993".

Medline reports the first page should be "17" not "7" in reference 15 "Montoro, Myers, Mestman, Xu, Anderson, Golde, 1993".

Table of Contents – Volume 22, Number 1—January 2016

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Annick Lenglet, MSF-Operational Centre Amsterdam, Plantage Middenlaan 14, 1018 DD, Amsterdam, the Netherlands


character(s) remaining.

Comment submitted successfully, thank you for your feedback.

Top

TOP